Lisa Gill
Stock Analyst at JP Morgan
(3.28)
# 1,030
Out of 5,146 analysts
138
Total ratings
51.06%
Success rate
1.96%
Average return
Main Sectors:
Stocks Rated by Lisa Gill
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LH Labcorp Holdings | Maintains: Overweight | $319 → $330 | $282.78 | +16.70% | 4 | Feb 18, 2026 | |
| CAH Cardinal Health | Maintains: Neutral | $209 → $243 | $226.18 | +7.44% | 7 | Feb 10, 2026 | |
| COR Cencora | Maintains: Overweight | $417 → $419 | $363.03 | +15.42% | 4 | Feb 10, 2026 | |
| MCK McKesson | Maintains: Overweight | $983 → $1,107 | $963.24 | +14.92% | 15 | Feb 10, 2026 | |
| ELV Elevance Health | Maintains: Overweight | $394 → $397 | $330.51 | +20.12% | 7 | Feb 2, 2026 | |
| UNH UnitedHealth Group | Maintains: Overweight | $425 → $389 | $284.20 | +36.88% | 11 | Feb 2, 2026 | |
| MDLN Medline | Initiates: Overweight | $50 | $48.18 | +3.78% | 1 | Jan 12, 2026 | |
| CVS CVS Health | Maintains: Overweight | $93 → $101 | $76.19 | +32.56% | 6 | Dec 17, 2025 | |
| ALHC Alignment Healthcare | Maintains: Overweight | $20 → $23 | $20.13 | +14.26% | 6 | Dec 17, 2025 | |
| PRVA Privia Health Group | Maintains: Overweight | $32 → $33 | $22.65 | +45.70% | 6 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $6 → $5 | $2.45 | +104.08% | 2 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $25 → $26 | $21.33 | +21.89% | 1 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $428 → $375 | $284.44 | +31.84% | 14 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $6 → $10 | $7.21 | +38.70% | 3 | Sep 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $180 → $190 | $207.80 | -8.57% | 3 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $29 → $30 | $23.39 | +28.26% | 2 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $40 → $41 | $33.60 | +22.02% | 4 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $257 → $256 | $176.06 | +45.40% | 6 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $18 | $39.31 | -54.21% | 2 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $5 | $8.90 | -43.82% | 4 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $38 → $28 | $15.49 | +80.76% | 4 | Dec 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $16 → $9 | $4.65 | +93.55% | 9 | Aug 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $18 | $9.86 | +82.56% | 1 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $420 → $395 | $145.55 | +171.38% | 2 | Jul 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $182 → $186 | $230.73 | -19.39% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $107 → $140 | $237.04 | -40.94% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $327 → $332 | $540.57 | -38.58% | 3 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $17 → $9 | $0.50 | +1,700.00% | 3 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $8 | $7.41 | +7.96% | 4 | Nov 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $83 | $81.91 | +1.33% | 1 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $103 → $98 | $42.69 | +129.56% | 1 | Jan 6, 2023 |
Labcorp Holdings
Feb 18, 2026
Maintains: Overweight
Price Target: $319 → $330
Current: $282.78
Upside: +16.70%
Cardinal Health
Feb 10, 2026
Maintains: Neutral
Price Target: $209 → $243
Current: $226.18
Upside: +7.44%
Cencora
Feb 10, 2026
Maintains: Overweight
Price Target: $417 → $419
Current: $363.03
Upside: +15.42%
McKesson
Feb 10, 2026
Maintains: Overweight
Price Target: $983 → $1,107
Current: $963.24
Upside: +14.92%
Elevance Health
Feb 2, 2026
Maintains: Overweight
Price Target: $394 → $397
Current: $330.51
Upside: +20.12%
UnitedHealth Group
Feb 2, 2026
Maintains: Overweight
Price Target: $425 → $389
Current: $284.20
Upside: +36.88%
Medline
Jan 12, 2026
Initiates: Overweight
Price Target: $50
Current: $48.18
Upside: +3.78%
CVS Health
Dec 17, 2025
Maintains: Overweight
Price Target: $93 → $101
Current: $76.19
Upside: +32.56%
Alignment Healthcare
Dec 17, 2025
Maintains: Overweight
Price Target: $20 → $23
Current: $20.13
Upside: +14.26%
Privia Health Group
Nov 13, 2025
Maintains: Overweight
Price Target: $32 → $33
Current: $22.65
Upside: +45.70%
Nov 11, 2025
Maintains: Overweight
Price Target: $6 → $5
Current: $2.45
Upside: +104.08%
Nov 11, 2025
Maintains: Neutral
Price Target: $25 → $26
Current: $21.33
Upside: +21.89%
Nov 4, 2025
Maintains: Overweight
Price Target: $428 → $375
Current: $284.44
Upside: +31.84%
Sep 18, 2025
Upgrades: Neutral
Price Target: $6 → $10
Current: $7.21
Upside: +38.70%
May 6, 2025
Maintains: Neutral
Price Target: $180 → $190
Current: $207.80
Upside: -8.57%
Mar 19, 2025
Maintains: Overweight
Price Target: $29 → $30
Current: $23.39
Upside: +28.26%
Mar 6, 2025
Maintains: Overweight
Price Target: $40 → $41
Current: $33.60
Upside: +22.02%
Feb 18, 2025
Maintains: Neutral
Price Target: $257 → $256
Current: $176.06
Upside: +45.40%
Dec 17, 2024
Downgrades: Neutral
Price Target: $18
Current: $39.31
Upside: -54.21%
Dec 17, 2024
Downgrades: Underweight
Price Target: $5
Current: $8.90
Upside: -43.82%
Dec 3, 2024
Maintains: Neutral
Price Target: $38 → $28
Current: $15.49
Upside: +80.76%
Aug 26, 2024
Maintains: Neutral
Price Target: $16 → $9
Current: $4.65
Upside: +93.55%
Aug 12, 2024
Initiates: Neutral
Price Target: $18
Current: $9.86
Upside: +82.56%
Jul 10, 2024
Maintains: Overweight
Price Target: $420 → $395
Current: $145.55
Upside: +171.38%
May 30, 2024
Maintains: Neutral
Price Target: $182 → $186
Current: $230.73
Upside: -19.39%
May 30, 2024
Maintains: Overweight
Price Target: $107 → $140
Current: $237.04
Upside: -40.94%
May 30, 2024
Maintains: Neutral
Price Target: $327 → $332
Current: $540.57
Upside: -38.58%
Jan 5, 2024
Downgrades: Neutral
Price Target: $17 → $9
Current: $0.50
Upside: +1,700.00%
Nov 17, 2023
Maintains: Neutral
Price Target: $10 → $8
Current: $7.41
Upside: +7.96%
Aug 9, 2023
Maintains: Neutral
Price Target: $80 → $83
Current: $81.91
Upside: +1.33%
Jan 6, 2023
Maintains: Overweight
Price Target: $103 → $98
Current: $42.69
Upside: +129.56%